Lightnews — Scholar-powered news

Reposted by Jon Salmanton-García

Oliver Cornely @olivercornely.bsky.social · 7d

Today & tomorrow in Madrid: the Invasive Fungal Infections Course 🦠 (Oct 1–2, 16:00–19:30 CET) at Hospital Gregorio Marañón. Free & online! 🔗 docs.google.com/forms/d/e/1F...
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸

2 2 4

Jon Salmanton-García @salmantongarcia.bsky.social · 8d

📢 Join us on 22 Oct 2025, 16:00–18:00 CEST for the #EPIRESEHA Webinar: Insights on Viral Respiratory Infections!

🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts

@olivercornely.bsky.social @salmantongarcia.bsky.social

Register 👉 uni-koeln.zoom.us/meeting/regi...

1 3 2

Jon Salmanton-García @salmantongarcia.bsky.social · 9d

🚨 Call for Papers 🚨

🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!

📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...

👉 Submit here: www.biomedcentral.com/collections/...

Jon Salmanton-García @salmantongarcia.bsky.social · 13d

Knowledge and capacity is not enough — it must be shared.

Over half the world is still waiting… and people are dying. Let’s act now.

Oliver Cornely @olivercornely.bsky.social · 18d

Today at #TIMM2025, @salmantongarcia.bsky.social inspired us with his vision for equitable fungal diagnostics 🌍🧫 – and even more special, he shared his birthday 🎂 with the community. Happy Birthday, Jon!

2

Jon Salmanton-García @salmantongarcia.bsky.social · 13d

Day starts early... #TheHague #DenHaag

1

Jon Salmanton-García @salmantongarcia.bsky.social · 20d

📊 #Rezafungin in real life 🌍🇪🇺🇺🇸

💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!

onlinelibrary.wiley.com/doi/epdf/10....

1

Jon Salmanton-García @salmantongarcia.bsky.social · 22d

🦠 Calling all #hematology researchers!

Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care

🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...

@frontiersin.bsky.social

Frontiers | Infections in Hematology: Advances in Diagnosis, Management, and Prevention in Benign and Malignant Disorders

Infections remain a leading cause of morbidity and mortality in patients with hematologic disorders, ranging from benign cytopenias to aggressive hematologic...

frontiersin.org

Reposted by Jon Salmanton-García

Oliver Cornely @olivercornely.bsky.social · 22d

📢 Presented at #MYK2025 by @salmantongarcia.bsky.social : Current trends on antifungal prophylaxis in solid organ transplantation – an ESCMID/SEIMC study exploring real-world practices to guide IFI management in transplant centers. #Transplant #Antifungals

3 3

Jon Salmanton-García @salmantongarcia.bsky.social · Sep 5

@institutpasteur.bsky.social Côte d'Ivoire 🇨🇮 tested RPA for rapid fungal diagnosis vs. traditional culture.

✅ 100% sensitivity + specificity for vaginal swabs
✅ Faster + field-friendly (days → minutes)
✅ Promising tool for low-resource settings

www.sciencedirect.com/science/arti...

Performance of Recombinase Polymerase Amplification-Based Assay (RPA) for rapid detection of fungal pathogens in clinical samples of patients in Abidjan, Côte d’Ivoire

The diversity of fungal species involved in medical mycology and the increasing rates of resistances make antifungal therapy increasingly challenging.…

www.sciencedirect.com

Jon Salmanton-García @salmantongarcia.bsky.social · Sep 5

🚨 #SOT from #HIV+ #donors to HIV+ #recipients in #Europe. Spanish perspective

✅ High acceptance among #ESP transplant teams
✅ 127 HIV+ organs discarded in '98–'19 could be used
✅ #ESP legalized HIV+ donation in '25

www.clinicalmicrobiologyandinfection.org/article/S119...

@seimc.bsky.social

Current Situation of Solid Organ Transplantation from HIV-Positive Donors to HIV-Positive Recipients in Europe. The Spanish Perspective.

There is limited information on the use of organs from HIV-positive donors (HIV D+) for HIV-positive recipients (HIV R+) in Europe. In some countries the use of HIV D+ organs is prohibited by law. Thi...

www.clinicalmicrobiologyandinfection.org

1

Reposted by Jon Salmanton-García

ESCMID Fungal Infection Study Group (EFISG) @efisg-escmid.bsky.social · Sep 1

🗓️ TOMORROW | 15:00 CET - Deadly fungal infections in HIV

🔗 us06web.zoom.us/webinar/regi...

O. Lortholary,FR – Cryptococcus, Pneumocystis and Talaromyces
A. Estévez,ES – Rare fungal infections in HIV
C. Oprea,RO – Clinical cases

@escmid.bsky.social @taescmid.bsky.social

1 4 3

Jon Salmanton-García @salmantongarcia.bsky.social · Aug 18

🦠 New @efisg-escmid.bsky.social study on persistent candidemia (n=1188) 🇮🇹🇪🇸
▫️ 25% persisted despite therapy
▫️ Linked to C. parapsilosis & C. auris
▫️ Source control protective
▫️ Persistence ↑ 30d mortality

🔗 www.journalofinfection.com/article/S016...

Jon Salmanton-García @salmantongarcia.bsky.social · Aug 12

📢🦠Jornadas de Actualización en Micología Clínica “Dra. Hilda Romero”

📅Sáb 30 AGO 2025 | 8:00-14:00
📍Auditorio Megalabs, Caracas y💻Virtual
🎙Expertos de 🇻🇪🇨🇴🇧🇷🇵🇾🇲🇽
💲Prof. $20 | Est. $10 | Online $20
🔗Registro: forms.gle/xAUJcaWw72y4...

✉ [email protected] | @avmycolve

Reposted by Jon Salmanton-García

Oliver Cornely @olivercornely.bsky.social · Jul 31

📌 New Review: Galactomannan in BAL fluid (≥1.01 ODI) is a reliable predictor for COVID-19-associated pulmonary aspergillosis (CAPA), while serum GM lacks diagnostic value.
🧪 Read more: doi.org/10.30699/ijp...
#CAPA #COVID19 #GMTest @salmantongarcia.bsky.social

The Value of the Galactomannan Test in Diagnosing COVID-19–Associated Pulmonary Aspergillosis: A Review

COVID–19–associated pulmonary aspergillosis (CAPA) is a complication of COVID-19. Galactomannan (GM) is a non-invasive test used to diagnose invasive aspergillosis. We collected the existing studies o...

doi.org

4 5

Reposted by Jon Salmanton-García

Oliver Cornely @olivercornely.bsky.social · Jul 30

🚨 Invasive fungal infections remain a major challenge in hematologic cancer care. Help shape future research by sharing your experience in our short survey (10–15 min):
👉 www.clinicalsurveys.net/uc/AFproph_HemMal
#Hematology #InfectiousDiseases #MedicalResearch

Survey

www.clinicalsurveys.net

4 5

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 30

“Country-tiered APC pricing” at its finest...

🇬🇾 Guyana = 🇱🇺 Luxembourg
🇪🇨 Ecuador = 🇧🇳 Brunei
🇨🇮 Côte d'Ivoire = 🇧🇭 Bahrain

Fair? Not really
These bargains are a joke — and #OpenAccess is still a luxury for MANY

#APCmadness #OpenAccess

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 23

🩸 Hematology #trainees — your voice matters!

💥 Improve ID training by sharing your experience in...

🔹 Infection care
🔹 Education
🔹 Confidence handling infections
🔹 Training satisfaction + needs

📋 10-min survey → www.clinicalsurveys.net/uc/ID_in_Hem...

Survey

www.clinicalsurveys.net

1 1

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 23

Tips from a local for #TIMM2025 in #Bilbao

Hotels within the transport area #1

Check flight companies flying to #Bilbao: en.wikipedia.org/wiki/Bilbao_...

2 2

Reposted by Jon Salmanton-García

Oliver Cornely @olivercornely.bsky.social · Jul 15

🎉 Congratulations to @salmantongarcia.bsky.social !
His paper was named one of the Top 10 Cited Articles in IJAA over the past 2 years – a testament to its impact!
Read it here: pubmed.ncbi.nlm.nih.gov/36640851/
#Mycology #Antimicrobials #TopCited #IJAA

The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM) - PubMed

According to the replies provided, the resources available for IFI diagnosis and management vary among Asia/Pacific countries/territories. Economical or geographical factors may play a key role in the...

pubmed.ncbi.nlm.nih.gov

3 5

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

🌍 With >250K fungal infections/year in 🇳🇱 and >230K in 🇧🇪, understanding how they're diagnosed and treated is essential 💪

🎯 Why does this matter?
Because early diagnosis and treatment save lives ❤️
And knowing the local landscape helps shape smarter health policies 🏥📘

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

📦 Everything in-house? Not quite…
🇧🇪 outsources far more tests (PCRs, TDM, etc.) than 🇳🇱 📤
That may impact diagnostic speed and clinical decision-making ⏱️🧠

1

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

💊 What about treatment?
✔️ Triazoles (fluco, isavu, vori, posa, itra) are widely available
✔️ But watch out — TDM is far more outsourced in 🇧🇪
✔️ Anidulafungin: 🧍‍♂️ marginal in 🇧🇪, 👑 king in 🇳🇱
✔️ Flucytosine and amphotericin B also covered — ✅ good job!

1

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

🔍 Diagnostics in detail:
✔️ Microscopy: used always in 69% of centers when IFI is suspected
✔️ Galactomannan: available in 94%
✔️ Aspergillus PCR: more common in 🇳🇱 than 🇧🇪
✔️ MALDI-TOF and β-D-glucan: widely implemented
🧬 Rising star? Molecular testing is gaining ground 💡

1

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

👀 Did you know up to 13% of Aspergillus fumigatus strains in 🇧🇪 and 🇳🇱 are azole-resistant? 😱 (Depends on the province...)

A serious threat for immunocompromised patients!

📈 This study shows how healthcare institutions are prepared to detect and fight it 💥

1

Jon Salmanton-García @salmantongarcia.bsky.social · Jul 14

🧪New @efisg-escmid.bsky.social study!

How 🇧🇪🇳🇱🇱🇺 diagnose and treat invasive #fungal infections

🔬 PCR, GM, MALDI-TOF MS, triazoles and more—big 🇧🇪 vs 🇳🇱 differences in diagnostics & access

📊 Must-read!

🧵

🔗 onlinelibrary.wiley.com/doi/10.1111/...

@escmid.bsky.social @olivercornely.bsky.social

ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

Introduction Invasive fungal infections (IFI) are a major clinical challenge, particularly in immunocompromised patients, and are associated with high morbidity and mortality. With the increasing pr.....

onlinelibrary.wiley.com

1 3 3